Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

61 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma

NCT00435916

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-Arizona Scottsdale, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
View all 14 locations
View Trial Details
Completed

Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL

NCT00655837

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of Colorado Aurora, Colorado, United States
  • Oncology Specialists Park Ridge, Illinois, United States
View Trial Details
Completed

A Safety Study in Patients With Chronic Lymphocytic Leukemia

NCT00283101

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Weill Medical College/Cornell University New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma

NCT00103779

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford University Stanford, California, United States
  • University of Miami Miami, Florida, United States
  • Cornell University New York, United States
View Trial Details
Completed

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

NCT00002048

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations
  • LaJolla Veterans Administration Med Ctr La Jolla, California, United States
  • AIDS Clinical Trials Group San Diego, California, United States
  • Georgetown Univ Med Ctr Washington D.C., District of Columbia, United States
  • Univ of Miami School of Medicine Miami, Florida, United States
View all 22 locations
View Trial Details

Related conditions